High rate of extensively drug-resistant tuberculosis in Indian AIDS patients
- 1 November 2007
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 21 (17), 2345-2347
- https://doi.org/10.1097/qad.0b013e3282f125c9
Abstract
Fifty-four full-blown AIDS patients suspected of having HIV-tuberculosis co-infection were investigated for the prevalence of extensively drug-resistant (XDR) Mycobacterium tuberculosis. Out of the 54 patients, M. tuberculosis was isolated from 24 (44.4%). Twelve (50%) isolates of these had resistance to first-line drugs, whereas four (33.33%) were also resistant to second-line drugs. All four patients, in whom XDR M. tuberculosis was isolated, died within 2.6 months of diagnosis.Keywords
This publication has 7 references indexed in Scilit:
- Controlling multidrug-resistant tuberculosis in IndiaThe Lancet, 2007
- Nontuberculous Mycobacterial Infections in Indian AIDS Patients Detected by a Novel Set of ESAT-6 Polymerase Chain Reaction PrimersJapanese Journal of Infectious Diseases, 2007
- Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysisThe Lancet, 2006
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaThe Lancet, 2006
- Extensively Drug‐Resistant Tuberculosis: 2 Years of Surveillance in IranClinical Infectious Diseases, 2006
- Multicenter Laboratory Validation of the BACTEC MGIT 960 Technique for Testing Susceptibilities of Mycobacterium tuberculosis to Classical Second-Line Drugs and Newer AntimicrobialsJournal of Clinical Microbiology, 2006
- The Global Problem of Multidrug-Resistant TuberculosisPublished by American Medical Association (AMA) ,2000